{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:40:58Z","timestamp":1793724058307,"version":"4.6.1"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2017,12,15]],"date-time":"2017-12-15T00:00:00Z","timestamp":1513296000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Gene Ther"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1038\/s41417-017-0002-1","type":"journal-article","created":{"date-parts":[[2017,12,14]],"date-time":"2017-12-14T23:12:28Z","timestamp":1513293148000},"page":"27-38","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Development of an adenovirus vector vaccine platform for targeting dendritic cells"],"prefix":"10.1038","volume":"25","author":[{"given":"Piyush K.","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor P.","family":"Dmitriev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena A.","family":"Kashentseva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geert","family":"Raes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel W.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Hong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey M.","family":"Arbeit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy P.","family":"Fleming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergey A.","family":"Kaliberov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Peter","family":"Goedegebuure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David T.","family":"Curiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William E.","family":"Gillanders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,12,15]]},"reference":[{"key":"2_CR1","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1586\/erv.09.1","volume":"8","author":"DC Tang","year":"2009","unstructured":"Tang DC, Zhang J, Toro H, Shi Z, Van Kampen KR. Adenovirus as a carrier for the development of influenza virus-free avian influenza vaccines. Expert Rev Vaccines 2009;8:469\u201381.","journal-title":"Expert Rev Vaccines"},{"key":"2_CR2","doi-asserted-by":"crossref","first-page":"e107903","DOI":"10.1371\/journal.pone.0107903","volume":"9","author":"S Biswas","year":"2014","unstructured":"Biswas S, Choudhary P, Elias SC, Miura K, Milne KH, de Cassan SC, et al. Assessment of humoral immune responses to blood-stage malaria antigens following ChAd63-MVA immunization, controlled human malaria infection and natural exposure. PLoS ONE 2014;9:e107903.","journal-title":"PLoS ONE"},{"key":"2_CR3","doi-asserted-by":"crossref","first-page":"e115161","DOI":"10.1371\/journal.pone.0115161","volume":"9","author":"E Barra de","year":"2014","unstructured":"de Barra E, Hodgson SH, Ewer KJ, Bliss CM, Hennigan K, Collins A, et al. A phase Ia study to assess the safety and immunogenicity of new malaria vaccine candidates ChAd63 CS administered alone and with MVA CS. PLoS ONE 2014;9:e115161.","journal-title":"PLoS ONE"},{"key":"2_CR4","doi-asserted-by":"crossref","first-page":"31344","DOI":"10.18632\/oncotarget.5181","volume":"6","author":"ES Gabitzsch","year":"2015","unstructured":"Gabitzsch ES, Tsang KY, Palena C, David JM, Fantini M, Kwilas A, et al. The generation and analyses of a novel combination of recombinant adenovirus vaccines targeting three tumor antigens as an immunotherapeutic. Oncotarget 2015;6:31344\u201359.","journal-title":"Oncotarget"},{"key":"2_CR5","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1056\/NEJMoa1310566","volume":"369","author":"SM Hammer","year":"2013","unstructured":"Hammer SM, Sobieszczyk ME, Janes H, Karuna ST, Mulligan MJ, Grove D, et al. Efficacy trial of a DNA\/rAd5 HIV-1 preventive vaccine. N Engl J Med. 2013;369:2083\u201392.","journal-title":"N Engl J Med."},{"key":"2_CR6","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1093\/infdis\/jiu579","volume":"211","author":"SH Hodgson","year":"2015","unstructured":"Hodgson SH, Ewer KJ, Bliss CM, Edwards NJ, Rampling T, Anagnostou NA, et al. Evaluation of the efficacy of ChAd63-MVA vectored vaccines expressing circumsporozoite protein and ME-TRAP against controlled human malaria infection in malaria-naive individuals. J Infect Dis. 2015;211:1076\u201386.","journal-title":"J Infect Dis."},{"key":"2_CR7","doi-asserted-by":"crossref","unstructured":"Ledgerwood JE, DeZure AD, Stanley DA, Coates EE, Novik L, Ename ME, et al. Chimpanzee Adenovirus Vector Ebola Vaccine. N Engl J Med. 2017;376:928\u2013938.","DOI":"10.1056\/NEJMoa1410863"},{"key":"2_CR8","doi-asserted-by":"crossref","unstructured":"Ewer K, Rampling T, Venkatraman N, Bowyer G, Wright D, Lambe T, et al. A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA. N Engl J Med. 2017;374:1635\u20131646.","DOI":"10.1056\/NEJMoa1411627"},{"key":"2_CR9","doi-asserted-by":"crossref","first-page":"e106241","DOI":"10.1371\/journal.pone.0106241","volume":"9","author":"M Sedegah","year":"2014","unstructured":"Sedegah M, Hollingdale MR, Farooq F, Ganeshan H, Belmonte M, Kim Y, et al. Sterile immunity to malaria after DNA prime\/adenovirus boost immunization is associated with effector memory CD8+T cells targeting AMA1 class I epitopes. PLoS ONE 2014;9:e106241.","journal-title":"PLoS ONE"},{"key":"2_CR10","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/CJI.0b013e31816a8910","volume":"31","author":"LH Butterfield","year":"2008","unstructured":"Butterfield LH, Comin-Anduix B, Vujanovic L, Lee Y, Dissette VB, Yang JQ, et al. Adenovirus MART-1-engineered autologous dendritic cell vaccine for metastatic melanoma. J Immunother. 2008;31:294\u2013309.","journal-title":"J Immunother."},{"key":"2_CR11","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1089\/vim.2005.18.283","volume":"18","author":"M Santosuosso","year":"2005","unstructured":"Santosuosso M, McCormick S, Xing Z. Adenoviral vectors for mucosal vaccination against infectious diseases. Viral Immunol. 2005;18:283\u201391.","journal-title":"Viral Immunol."},{"key":"2_CR12","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/sj.mt.6300031","volume":"15","author":"V Cerullo","year":"2007","unstructured":"Cerullo V, Seiler MP, Mane V, Brunetti-Pierri N, Clarke C, Bertin TK, et al. Toll-like receptor 9 triggers an innate immune response to helper-dependent adenoviral vectors. Mol Ther. 2007;15:378\u201385.","journal-title":"Mol Ther."},{"key":"2_CR13","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.virol.2006.08.041","volume":"358","author":"ZC Hartman","year":"2007","unstructured":"Hartman ZC, Black EP, Amalfitano A. Adenoviral infection induces a multi-faceted innate cellular immune response that is mediated by the toll-like receptor pathway in A549 cells. Virology 2007;358:357\u201372.","journal-title":"Virology"},{"key":"2_CR14","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1089\/hum.2008.141","volume":"20","author":"X Huang","year":"2009","unstructured":"Huang X, Yang Y. Innate immune recognition of viruses and viral vectors. Hum Gene Ther. 2009;20:293\u2013301.","journal-title":"Hum Gene Ther."},{"key":"2_CR15","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0092-8674(93)90231-E","volume":"73","author":"TJ Wickham","year":"1993","unstructured":"Wickham TJ, Mathias P, Cheresh DA, Nemerow GR. Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment. Cell 1993;73:309\u201319.","journal-title":"Cell"},{"key":"2_CR16","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1126\/science.275.5304.1320","volume":"275","author":"JM Bergelson","year":"1997","unstructured":"Bergelson JM, Cunningham JA, Droguett G, Kurt-Jones EA, Krithivas A, Hong JS, et al. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science 1997;275:1320\u20133.","journal-title":"Science"},{"key":"2_CR17","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/nri746","volume":"2","author":"K Shortman","year":"2002","unstructured":"Shortman K, Liu YJ. Mouse and human dendritic cell subtypes. Nat Rev Immunol. 2002;2:151\u201361.","journal-title":"Nat Rev Immunol."},{"key":"2_CR18","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1182\/blood-2012-09-452078","volume":"121","author":"M Kreutz","year":"2013","unstructured":"Kreutz M, Tacken PJ, Figdor CG. Targeting dendritic cells--why bother? Blood 2013;121:2836\u201344.","journal-title":"Blood"},{"key":"2_CR19","first-page":"139","volume":"246","author":"L Timares","year":"2004","unstructured":"Timares L, Douglas JT, Tillman BW, Krasnykh V, Curiel DT. Adenovirus-mediated gene delivery to dendritic cells. Methods Mol Biol. 2004;246:139\u201354.","journal-title":"Methods Mol Biol."},{"key":"2_CR20","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1016\/S0264-410X(03)00050-1","volume":"21","author":"JG Brandao","year":"2003","unstructured":"Brandao JG, Scheper RJ, Lougheed SM, Curiel DT, Tillman BW, Gerritsen WR, et al. CD40-targeted adenoviral gene transfer to dendritic cells through the use of a novel bispecific single-chain Fv antibody enhances cytotoxic T cell activation. Vaccine 2003;21:2268\u201372.","journal-title":"Vaccine"},{"key":"2_CR21","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.ymthe.2004.02.006","volume":"9","author":"AV Pereboev","year":"2004","unstructured":"Pereboev AV, Nagle JM, Shakhmatov MA, Triozzi PL, Matthews QL, Kawakami Y, et al. Enhanced gene transfer to mouse dendritic cells using adenoviral vectors coated with a novel adapter molecule. Mol Ther. 2004;9:712\u201320.","journal-title":"Mol Ther."},{"key":"2_CR22","doi-asserted-by":"crossref","first-page":"5827","DOI":"10.1158\/0008-5472.CAN-11-0804","volume":"71","author":"BN Hangalapura","year":"2011","unstructured":"Hangalapura BN, Oosterhoff D, de Groot J, Boon L, Tuting T, van den Eertwegh AJ, et al. Potent antitumor immunity generated by a CD40-targeted adenoviral vaccine. Cancer Res. 2011;71:5827\u201337.","journal-title":"Cancer Res."},{"key":"2_CR23","doi-asserted-by":"crossref","first-page":"e46981","DOI":"10.1371\/journal.pone.0046981","volume":"7","author":"BJ Williams","year":"2012","unstructured":"Williams BJ, Bhatia S, Adams LK, Boling S, Carroll JL, Li XL, et al. Dendritic cell based PSMA immunotherapy for prostate cancer using a CD40-targeted adenovirus vector. PLoS ONE 2012;7:e46981.","journal-title":"PLoS ONE"},{"key":"2_CR24","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1021\/mp050002w","volume":"2","author":"N Korokhov","year":"2005","unstructured":"Korokhov N, Noureddini SC, Curiel DT, Santegoets SJ, Scheper RJ, de Gruijl TD. A single-component CD40-targeted adenovirus vector displays highly efficient transduction and activation of dendritic cells in a human skin substrate system. Mol Pharm. 2005;2:218\u201323.","journal-title":"Mol Pharm."},{"key":"2_CR25","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1097\/CJI.0b013e3181eccbd4","volume":"33","author":"BN Hangalapura","year":"2010","unstructured":"Hangalapura BN, Oosterhoff D, Aggarwal S, Wijnands PG, van de Ven R, Santegoets SJ, et al. Selective transduction of dendritic cells in human lymph nodes and superior induction of high-avidity melanoma-reactive cytotoxic T cells by a CD40-targeted adenovirus. J Immunother. 2010;33:706\u201315.","journal-title":"J Immunother."},{"key":"2_CR26","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/jgm.1648","volume":"14","author":"BN Hangalapura","year":"2012","unstructured":"Hangalapura BN, Timares L, Oosterhoff D, Scheper RJ, Curiel DT, de Gruijl TD. CD40-targeted adenoviral cancer vaccines: the long and winding road to the clinic. J Gene Med. 2012;14:416\u201327.","journal-title":"J Gene Med."},{"key":"2_CR27","doi-asserted-by":"crossref","first-page":"788","DOI":"10.2967\/jnumed.107.048538","volume":"49","author":"LO Gainkam","year":"2008","unstructured":"Gainkam LO, Huang L, Caveliers V, Keyaerts M, Hernot S, Vaneycken I, et al. Comparison of the biodistribution and tumor targeting of two 99mTc-labeled anti-EGFR nanobodies in mice, using pinhole SPECT\/micro-CT. J Nucl Med. 2008;49:788\u201395.","journal-title":"J Nucl Med."},{"key":"2_CR28","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s11307-008-0133-8","volume":"10","author":"L Huang","year":"2008","unstructured":"Huang L, Gainkam LO, Caveliers V, Vanhove C, Keyaerts M, De Baetselier P, et al. SPECT imaging with 99mTc-labeled EGFR-specific nanobody for in vivo monitoring of EGFR expression. Mol Imaging Biol. 2008;10:167\u201375.","journal-title":"Mol Imaging Biol."},{"key":"2_CR29","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1074\/jbc.M806889200","volume":"284","author":"C Vincke","year":"2009","unstructured":"Vincke C, Loris R, Saerens D, Martinez-Rodriguez S, Muyldermans S, Conrath K. General strategy to humanize a camelid single-domain antibody and identification of a universal humanized nanobody scaffold. J Biol Chem. 2009;284:3273\u201384.","journal-title":"J Biol Chem."},{"key":"2_CR30","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.virusres.2005.10.002","volume":"116","author":"SC Noureddini","year":"2006","unstructured":"Noureddini SC, Krendelshchikov A, Simonenko V, Hedley SJ, Douglas JT, Curiel DT, et al. Generation and selection of targeted adenoviruses embodying optimized vector properties. Virus Res. 2006;116:185\u201395.","journal-title":"Virus Res."},{"key":"2_CR31","doi-asserted-by":"crossref","first-page":"11367","DOI":"10.1128\/JVI.77.21.11367-11377.2003","volume":"77","author":"N Belousova","year":"2003","unstructured":"Belousova N, Korokhov N, Krendelshchikova V, Simonenko V, Mikheeva G, Triozzi PL, et al. Genetically targeted adenovirus vector directed to CD40-expressing cells. J Virol. 2003;77:11367\u201377.","journal-title":"J Virol."},{"key":"2_CR32","doi-asserted-by":"crossref","first-page":"4176","DOI":"10.1128\/JVI.75.9.4176-4183.2001","volume":"75","author":"V Krasnykh","year":"2001","unstructured":"Krasnykh V, Belousova N, Korokhov N, Mikheeva G, Curiel DT. Genetic targeting of an adenovirus vector via replacement of the fiber protein with the phage T4 fibritin. J Virol. 2001;75:4176\u201383.","journal-title":"J Virol."},{"key":"2_CR33","doi-asserted-by":"crossref","first-page":"e37812","DOI":"10.1371\/journal.pone.0037812","volume":"7","author":"MO Alberti","year":"2012","unstructured":"Alberti MO, Roth JC, Ismail M, Tsuruta Y, Abraham E, Pereboeva L, et al. Derivation of a myeloid cell-binding adenovirus for gene therapy of inflammation. PLoS ONE 2012;7:e37812.","journal-title":"PLoS ONE"},{"key":"2_CR34","doi-asserted-by":"crossref","first-page":"782","DOI":"10.2967\/jnumed.109.070078","volume":"51","author":"K Groeve De","year":"2010","unstructured":"De Groeve K, Deschacht N, De Koninck C, Caveliers V, Lahoutte T, Devoogdt N, et al. Nanobodies as tools for in vivo imaging of specific immune cell types. J Nucl Med. 2010;51:782\u20139.","journal-title":"J Nucl Med."},{"key":"2_CR35","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1128\/JVI.73.2.1601-1608.1999","volume":"73","author":"DJ Seggern Von","year":"1999","unstructured":"Von Seggern DJ, Chiu CY, Fleck SK, Stewart PL, Nemerow GR. A helper-independent adenovirus vector with E1, E3, and fiber deleted: structure and infectivity of fiberless particles. J Virol. 1999;73:1601\u20138.","journal-title":"J Virol"},{"key":"2_CR36","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.4049\/jimmunol.158.6.2723","volume":"158","author":"Z Shen","year":"1997","unstructured":"Shen Z, Reznikoff G, Dranoff G, Rock KL. Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules. J Immunol. 1997;158:2723\u201330.","journal-title":"J Immunol."},{"key":"2_CR37","doi-asserted-by":"crossref","first-page":"12716","DOI":"10.1073\/pnas.1203468109","volume":"109","author":"L Li","year":"2012","unstructured":"Li L, Kim S, Herndon JM, Goedegebuure P, Belt BA, Satpathy AT, et al. Cross-dressed CD8alpha+\/CD103+ dendritic cells prime CD8+T cells following vaccination. Proc Natl Acad Sci USA 2012;109:12716\u201321.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2_CR38","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/labinvest.2014.82","volume":"94","author":"SA Kaliberov","year":"2014","unstructured":"Kaliberov SA, Kaliberova LN, Buggio M, Tremblay JM, Shoemaker CB, Curiel DT. Adenoviral targeting using genetically incorporated camelid single variable domains. Lab Invest. 2014;94:893\u2013905.","journal-title":"Lab Invest."},{"key":"2_CR39","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/8647","volume":"17","author":"JT Douglas","year":"1999","unstructured":"Douglas JT, Miller CR, Kim M, Dmitriev I, Mikheeva G, Krasnykh V, et al. A system for the propagation of adenoviral vectors with genetically modified receptor specificities. Nat Biotechnol. 1999;17:470\u20135.","journal-title":"Nat Biotechnol."},{"key":"2_CR40","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1128\/AAC.45.10.2807-2812.2001","volume":"45","author":"KE Conrath","year":"2001","unstructured":"Conrath KE, Lauwereys M, Galleni M, Matagne A, Frere JM, Kinne J, et al. Beta-lactamase inhibitors derived from single-domain antibody fragments elicited in the camelidae. Antimicrob Agents Chemother. (Bethesda) 2001;45:2807\u201312.","journal-title":"Antimicrob Agents Chemother. (Bethesda)"},{"key":"2_CR41","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1084\/jem.194.6.769","volume":"194","author":"D Hawiger","year":"2001","unstructured":"Hawiger D, Inaba K, Dorsett Y, Guo M, Mahnke K, Rivera M, et al. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J Exp Med. 2001;194:769\u201379.","journal-title":"J Exp Med."},{"key":"2_CR42","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1083\/jcb.151.3.673","volume":"151","author":"K Mahnke","year":"2000","unstructured":"Mahnke K, Guo M, Lee S, Sepulveda H, Swain SL, Nussenzweig M, et al. The dendritic cell receptor for endocytosis, DEC-205, can recycle and enhance antigen presentation via major histocompatibility complex class II-positive lysosomal compartments. J Cell Biol. 2000;151:673\u201384.","journal-title":"J Cell Biol."},{"key":"2_CR43","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/jgm.285","volume":"4","author":"MK Magnusson","year":"2002","unstructured":"Magnusson MK, Hong SS, Henning P, Boulanger P, Lindholm L. Genetic retargeting of adenovirus vectors: functionality of targeting ligands and their influence on virus viability. J Gene Med. 2002;4:356\u201370.","journal-title":"J Gene Med."},{"key":"2_CR44","doi-asserted-by":"crossref","first-page":"10074","DOI":"10.1128\/JVI.02665-09","volume":"84","author":"KL Poulin","year":"2010","unstructured":"Poulin KL, Lanthier RM, Smith AC, Christou C, Risco Quiroz M, Powell KL, et al. Retargeting of adenovirus vectors through genetic fusion of a single-chain or single-domain antibody to capsid protein IX. J Virol. 2010;84:10074\u201386.","journal-title":"J Virol."},{"key":"2_CR45","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/nbt0897-772","volume":"15","author":"K Nord","year":"1997","unstructured":"Nord K, Gunneriusson E, Ringdahl J, Stahl S, Uhlen M, Nygren PA. Binding proteins selected from combinatorial libraries of an alpha-helical bacterial receptor domain. Nat Biotechnol. 1997;15:772\u20137.","journal-title":"Nat Biotechnol."},{"key":"2_CR46","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1089\/10430340260185067","volume":"13","author":"P Henning","year":"2002","unstructured":"Henning P, Magnusson MK, Gunneriusson E, Hong SS, Boulanger P, Nygren PA, et al. Genetic modification of adenovirus 5 tropism by a novel class of ligands based on a three-helix bundle scaffold derived from staphylococcal protein A. Hum Gene Ther. 2002;13:1427\u201339.","journal-title":"Hum Gene Ther."},{"key":"2_CR47","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/sj.cgt.7701027","volume":"14","author":"MK Magnusson","year":"2007","unstructured":"Magnusson MK, Henning P, Myhre S, Wikman M, Uil TG, Friedman M, et al. Adenovirus 5 vector genetically re-targeted by an affibody molecule with specificity for tumor antigen HER2\/neu. Cancer Gene Ther. 2007;14:468\u201379.","journal-title":"Cancer Gene Ther."},{"key":"2_CR48","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1128\/JVI.01896-07","volume":"82","author":"N Belousova","year":"2008","unstructured":"Belousova N, Mikheeva G, Gelovani J, Krasnykh V. Modification of adenovirus capsid with a designed protein ligand yields a gene vector targeted to a major molecular marker of cancer. J Virol. 2008;82:630\u20137.","journal-title":"J Virol."},{"key":"2_CR49","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/gt.2008.160","volume":"16","author":"S Myhre","year":"2009","unstructured":"Myhre S, Henning P, Friedman M, Stahl S, Lindholm L, Magnusson MK. Re-targeted adenovirus vectors with dual specificity; binding specificities conferred by two different affibody molecules in the fiber. Gene Ther. 2009;16:252\u201361.","journal-title":"Gene Ther"},{"key":"2_CR50","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1089\/hum.2011.016","volume":"23","author":"MK Magnusson","year":"2012","unstructured":"Magnusson MK, Kraaij R, Leadley RM, De Ridder CM, van Weerden WM, Van Schie KA, et al. A transductionally retargeted adenoviral vector for virotherapy of Her2\/neu-expressing prostate cancer. Hum Gene Ther. 2012;23:70\u201382.","journal-title":"Hum Gene Ther."},{"key":"2_CR51","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/sj.gt.3303085","volume":"15","author":"D Huang","year":"2008","unstructured":"Huang D, Pereboev AV, Korokhov N, He R, Larocque L, Gravel C, et al. Significant alterations of biodistribution and immune responses in Balb\/c mice administered with adenovirus targeted to CD40(+) cells. Gene Ther. 2008;15:298\u2013308.","journal-title":"Gene Ther."},{"key":"2_CR52","doi-asserted-by":"crossref","first-page":"7116","DOI":"10.1016\/j.vaccine.2009.09.055","volume":"27","author":"EE Thacker","year":"2009","unstructured":"Thacker EE, Nakayama M, Smith BF, Bird RC, Muminova Z, Strong TV, et al. A genetically engineered adenovirus vector targeted to CD40 mediates transduction of canine dendritic cells and promotes antigen-specific immune responses in vivo. Vaccine 2009;27:7116\u201324.","journal-title":"Vaccine"},{"key":"2_CR53","doi-asserted-by":"crossref","first-page":"6378","DOI":"10.4049\/jimmunol.162.11.6378","volume":"162","author":"BW Tillman","year":"1999","unstructured":"Tillman BW, de Gruijl TD, Luykx-de Bakker SA, Scheper RJ, Pinedo HM, Curiel TJ, et al. Maturation of dendritic cells accompanies high-efficiency gene transfer by a CD40-targeted adenoviral vector. J Immunol. 1999;162:6378\u201383","journal-title":"J Immunol."},{"key":"2_CR54","first-page":"5456","volume":"60","author":"BW Tillman","year":"2000","unstructured":"Tillman BW, Hayes TL, DeGruijl TD, Douglas JT, Curiel DT. Adenoviral vectors targeted to CD40 enhance the efficacy of dendritic cell-based vaccination against human papillomavirus 16-induced tumor cells in a murine model. Cancer Res. 2000;60:5456\u201363.","journal-title":"Cancer Res."},{"key":"2_CR55","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1038\/sj.gt.3301767","volume":"9","author":"AV Pereboev","year":"2002","unstructured":"Pereboev AV, Asiedu CK, Kawakami Y, Dong SS, Blackwell JL, Kashentseva EA, et al. Coxsackievirus-adenovirus receptor genetically fused to anti-human CD40 scFv enhances adenoviral transduction of dendritic cells. Gene Ther. 2002;9:1189\u201393.","journal-title":"Gene Ther."},{"key":"2_CR56","doi-asserted-by":"crossref","first-page":"5322","DOI":"10.4049\/jimmunol.169.9.5322","volume":"169","author":"TD Gruijl de","year":"2002","unstructured":"de Gruijl TD, Luykx-de Bakker SA, Tillman BW, van den Eertwegh AJ, Buter J, Lougheed SM, et al. Prolonged maturation and enhanced transduction of dendritic cells migrated from human skin explants after in situ delivery of CD40-targeted adenoviral vectors. J Immunol. 2002;169:5322\u201331.","journal-title":"J Immunol."},{"key":"2_CR57","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.0105-2896.2009.00868.x","volume":"234","author":"K Crozat","year":"2010","unstructured":"Crozat K, Guiton R, Guilliams M, Henri S, Baranek T, Schwartz-Cornil I, et al. Comparative genomics as a tool to reveal functional equivalences between human and mouse dendritic cell subsets. Immunol Rev. 2010;234:177\u201398.","journal-title":"Immunol Rev."},{"key":"2_CR58","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1002\/eji.201040498","volume":"40","author":"M Guilliams","year":"2010","unstructured":"Guilliams M, Henri S, Tamoutounour S, Ardouin L, Schwartz-Cornil I, Dalod M, et al. From skin dendritic cells to a simplified classification of human and mouse dendritic cell subsets. Eur J Immunol. 2010;40:2089\u201394.","journal-title":"Eur J Immunol."},{"key":"2_CR59","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.0105-2896.2004.00142.x","volume":"199","author":"WR Heath","year":"2004","unstructured":"Heath WR, Belz GT, Behrens GM, Smith CM, Forehan SP, Parish IA, et al. Cross-presentation, dendritic cell subsets, and the generation of immunity to cellular antigens. Immunol Rev. 2004;199:9\u201326.","journal-title":"Immunol Rev."},{"key":"2_CR60","doi-asserted-by":"crossref","first-page":"5937","DOI":"10.4049\/jimmunol.1500089","volume":"194","author":"Y Zhang","year":"2015","unstructured":"Zhang Y, Chen G, Liu Z, Tian S, Zhang J, Carey CD, et al. Genetic vaccines to potentiate the effective CD103+ dendritic cell-mediated cross-priming of antitumor immunity. J Immunol. 2015;194:5937\u201347.","journal-title":"J Immunol."},{"key":"2_CR61","doi-asserted-by":"crossref","first-page":"214","DOI":"10.3389\/fimmu.2012.00214","volume":"3","author":"A Bachem","year":"2012","unstructured":"Bachem A, Hartung E, Guttler S, Mora A, Zhou X, Hegemann A, et al. Expression of XCR1 characterizes the Batf3-dependent lineage of dendritic cells capable of antigen cross-presentation. Front Immunol. 2012;3:214.","journal-title":"Front Immunol."},{"key":"2_CR62","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1084\/jem.20100223","volume":"207","author":"K Crozat","year":"2010","unstructured":"Crozat K, Guiton R, Contreras V, Feuillet V, Dutertre CA, Ventre E, et al. The XC chemokine receptor 1 is a conserved selective marker of mammalian cells homologous to mouse CD8alpha+ dendritic cells. J Exp Med. 2010;207:1283\u201392.","journal-title":"J Exp Med."},{"key":"2_CR63","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1084\/jem.184.3.903","volume":"184","author":"L Wu","year":"1996","unstructured":"Wu L, Li CL, Shortman K. Thymic dendritic cell precursors: relationship to the T lymphocyte lineage and phenotype of the dendritic cell progeny. J Exp Med. 1996;184:903\u201311.","journal-title":"J Exp Med."},{"key":"2_CR64","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/jlb.66.2.205","volume":"66","author":"RM Steinman","year":"1999","unstructured":"Steinman RM, Inaba K. Myeloid dendritic cells. J Leukoc Biol. 1999;66:205\u20138.","journal-title":"J Leukoc Biol."},{"key":"2_CR65","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/jlb.66.2.242","volume":"66","author":"R Maldonado-Lopez","year":"1999","unstructured":"Maldonado-Lopez R, De Smedt T, Pajak B, Heirman C, Thielemans K, Leo O, et al. Role of CD8alpha+ and CD8alpha- dendritic cells in the induction of primary immune responses in vivo. J Leukoc Biol. 1999;66:242\u20136.","journal-title":"J Leukoc Biol."},{"key":"2_CR66","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1073\/pnas.96.3.1036","volume":"96","author":"B Pulendran","year":"1999","unstructured":"Pulendran B, Smith JL, Caspary G, Brasel K, Pettit D, Maraskovsky E, et al. Distinct dendritic cell subsets differentially regulate the class of immune response in vivo. Proc Natl Acad Sci USA 1999;96:1036\u201341.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2_CR67","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/375151a0","volume":"375","author":"W Jiang","year":"1995","unstructured":"Jiang W, Swiggard WJ, Heufler C, Peng M, Mirza A, Steinman RM, et al. The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing. Nature 1995;375:151\u20135.","journal-title":"Nature"},{"key":"2_CR68","doi-asserted-by":"crossref","first-page":"pii:E8","DOI":"10.3390\/vaccines4020008","volume":"4","author":"CH Lehmann","year":"2016","unstructured":"Lehmann CH, Heger L, Heidkamp GF, Baranska A, Luhr JJ, Hoffmann A, et al. Direct delivery of antigens to dendritic cells via antibodies specific for endocytic receptors as a promising strategy for future therapies. Vaccines 2016;4:pii:E8.","journal-title":"Vaccines"},{"key":"2_CR69","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1073\/pnas.1019547108","volume":"108","author":"J Idoyaga","year":"2011","unstructured":"Idoyaga J, Lubkin A, Fiorese C, Lahoud MH, Caminschi I, Huang Y, et al. Comparable T helper 1 (Th1) and CD8 T-cell immunity by targeting HIV gag p24 to CD8 dendritic cells within antibodies to Langerin, DEC205, and Clec9A. Proc Natl Acad Sci USA 2011;108:2384\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2_CR70","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/gt.2011.206","volume":"19","author":"C Goyvaerts","year":"2012","unstructured":"Goyvaerts C, De Groeve K, Dingemans J, Van Lint S, Robays L, Heirman C, et al. Development of the nanobody display technology to target lentiviral vectors to antigen-presenting cells. Gene Ther. 2012;19:1133\u201340.","journal-title":"Gene Ther."},{"key":"2_CR71","doi-asserted-by":"crossref","unstructured":"Goyvaerts C, Dingemans J, De Groeve K, Heirman C, Van Gulck E, Vanham G, et al. Targeting of human antigen-presenting cell subsets. J Virol. 2013;87:11304\u201311308.","DOI":"10.1128\/JVI.01498-13"},{"key":"2_CR72","doi-asserted-by":"crossref","first-page":"704","DOI":"10.18632\/oncotarget.1680","volume":"5","author":"C Goyvaerts","year":"2014","unstructured":"Goyvaerts C, Kurt de G, Van Lint S, Heirman C, Van Ginderachter JA, De Baetselier P, et al. Immunogenicity of targeted lentivectors. Oncotarget 2014;5:704\u201315.","journal-title":"Oncotarget"}],"container-title":["Cancer Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41417-017-0002-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41417-017-0002-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41417-017-0002-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T23:04:13Z","timestamp":1693350253000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41417-017-0002-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,15]]},"references-count":72,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["2"],"URL":"https:\/\/doi.org\/10.1038\/s41417-017-0002-1","relation":{},"ISSN":["0929-1903","1476-5500"],"issn-type":[{"value":"0929-1903","type":"print"},{"value":"1476-5500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,15]]}}}